Public Policy Resources

Share

Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing

August 2, 2022

Pharmacogenomic (PGx) testing (also known as pharmacogenomic biomarker testing) is a component of precision medicine that involves examining a patient’s inherited genes to detect variations that may impact the way a drug is broken down, absorbed and used within the body. Sometimes these variations can impact the safety and effectiveness of treatment. The same treatment given to patients with the same disease can produce different responses based on each person's inherited genes.

PDF icon Download Pharmacogenomic (PGx) Testing Factsheet

Related Resources

Equidad en salud en las pruebas de biomarcadores y terapias dirigidas

February 15, 2024

La terapia dirigida puede mejorar la supervivencia y la calidad de vida al conectar a los pacientes con el tratamiento más beneficioso para su enfermedad.

Read more

Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment

October 19, 2023

Our latest Survivor Views survey sees increases in biomarker testing since the question was last asked three years ago along with reduced cost and coverage barriers in that time. Cancer patients and survivors describe the benefits and overwhelmingly agree biomarker testing gave their providers information that improved their treatment. 

Read more